Form 8-K - Current report:
SEC Accession No. 0001104659-25-101282
Filing Date
2025-10-21
Accepted
2025-10-21 16:56:49
Documents
12
Period of Report
2025-10-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2529201d1_8k.htm   iXBRL 8-K 26733
  Complete submission text file 0001104659-25-101282.txt   192519

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA rzlt-20251017.xsd EX-101.SCH 3023
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE rzlt-20251017_lab.xml EX-101.LAB 34239
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rzlt-20251017_pre.xml EX-101.PRE 22364
14 EXTRACTED XBRL INSTANCE DOCUMENT tm2529201d1_8k_htm.xml XML 3680
Mailing Address 275 SHORELINE DRIVE, SUITE 500 REDWOOD CITY CA 94065
Business Address 275 SHORELINE DRIVE, SUITE 500 REDWOOD CITY CA 94065 650-206-4507
Rezolute, Inc. (Filer) CIK: 0001509261 (see all company filings)

EIN.: 273440894 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39683 | Film No.: 251407751
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)